Probiotics ban leads to marketing revolution
date:Aug 10, 2012
It includes two documents advising on how manufacturers can justify health claims for their products when seeking approval.

They are the last two in a series of six which had already covered claims related to gut and immune function; antioxidants and cardiovascular health; weight management; and bone, joints and oral health.

Issues addressed in the documents include definitions of beneficial physiological effects and the type of evidence that will be required to substantiate a claim.

EFSA ha
7/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/10 16:04